BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15902132)

  • 1. The effect of short-term indomethacin therapy on amniotic fluid volume.
    Sandruck JC; Grobman WA; Gerber SE
    Am J Obstet Gynecol; 2005 May; 192(5):1443-5. PubMed ID: 15902132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term indomethacin therapy decreases fetal urine output and results in oligohydramnios.
    Kirshon B; Moise KJ; Mari G; Willis R
    Am J Perinatol; 1991 Mar; 8(2):86-8. PubMed ID: 2006947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligohydramnios induced by maternal indomethacin therapy.
    Uslu T; Ozcan FS; Aydin C
    Int J Clin Pharmacol Ther Toxicol; 1992 Jul; 30(7):230-2. PubMed ID: 1506126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of prolonged indomethacin therapy.
    Savage AH; Anderson BL; Simhan HN
    Am J Perinatol; 2007 Apr; 24(4):207-13. PubMed ID: 17447185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of indomethacin on individual amniotic fluid indices in multiple gestations.
    Hill LM; Lazebnik N; Many A
    J Ultrasound Med; 1996 May; 15(5):395-9. PubMed ID: 8731448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing amniotic fluid magnesium concentrations with stable maternal serum levels: a prospective clinical trial.
    Gortzak-Uzan L; Mezad D; Smolin A; Friger M; Huleihel M; Hallak M
    J Reprod Med; 2005 Nov; 50(11):817-20. PubMed ID: 16419627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
    de la Torre L; Istwan NB; Desch C; Rhea DJ; Roca L; Stanziano GJ; González-Quintero VH
    Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind randomized study of fetal side effects during and after the short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor.
    Sawdy RJ; Lye S; Fisk NM; Bennett PR
    Am J Obstet Gynecol; 2003 Apr; 188(4):1046-51. PubMed ID: 12712108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifedipine for the treatment of preterm labor in twin and singleton pregnancies.
    Derbent A; Simavli S; Gümüş II; Tatli MM; Turhan NO
    Arch Gynecol Obstet; 2011 Oct; 284(4):821-6. PubMed ID: 21072527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligohydramnios in each sac of a triplet gestation caused by Motrin--fulfilling Kock's postulates.
    Wiggins DA; Elliott JP
    Am J Obstet Gynecol; 1990 Feb; 162(2):460-1. PubMed ID: 2309829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study.
    Morales WJ; Smith SG; Angel JL; O'Brien WF; Knuppel RA
    Obstet Gynecol; 1989 Oct; 74(4):567-72. PubMed ID: 2677863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good fetal outcome following prolonged indomethacin induced anhydramnios. Case report.
    Shen O; Rabinowitz R; Lavie O; Aboulafia Y; Diamant YZ
    J Perinat Med; 1995; 23(3):233-6. PubMed ID: 8568616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparative trial of indomethacin and sulindac for the treatment of refractory preterm labor.
    Carlan SJ; O'Brien WF; O'Leary TD; Mastrogiannis D
    Obstet Gynecol; 1992 Feb; 79(2):223-8. PubMed ID: 1731289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized clinical trial comparing the effect of maternal intravenous hydration and placebo on the amniotic fluid index in oligohydramnios.
    Yan-Rosenberg L; Burt B; Bombard AT; Callado-Khoury F; Sharett L; Julliard K; Weiner Z
    J Matern Fetal Neonatal Med; 2007 Oct; 20(10):715-8. PubMed ID: 17763271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and adverse effects of nifedipine and indomethacin for the treatment of preterm labor.
    Kashanian M; Bahasadri S; Zolali B
    Int J Gynaecol Obstet; 2011 Jun; 113(3):192-5. PubMed ID: 21457979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The controversy surrounding indomethacin for tocolysis.
    Macones GA; Marder SJ; Clothier B; Stamilio DM
    Am J Obstet Gynecol; 2001 Feb; 184(3):264-72. PubMed ID: 11228471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous maternal hydration in third trimester oligohydramnios: effect on amniotic fluid volume.
    Umber A; Chohan MA
    J Coll Physicians Surg Pak; 2007 Jun; 17(6):336-9. PubMed ID: 17623581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interval to spontaneous delivery following discontinuation of maintenance tocolysis.
    Jones JS; Morrison J; Istwan N; Rhea D; Collins A; Stanziano G
    J Matern Fetal Neonatal Med; 2006 Jun; 19(6):331-5. PubMed ID: 16801308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin in pregnancy: applications and safety.
    Abou-Ghannam G; Usta IM; Nassar AH
    Am J Perinatol; 2012 Mar; 29(3):175-86. PubMed ID: 21786219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute renal failure in the neonate induced by the administration of indomethacin as a tocolytic agent.
    Pomeranz A; Korzets Z; Dolfin Z; Eliakim A; Bernheim J; Wolach B
    Nephrol Dial Transplant; 1996 Jun; 11(6):1139-41. PubMed ID: 8671983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.